Bayer AG

Bayer to use Mammoth’s CRISPR systems for the development of vivo gene-editing therapies

Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the full potential of…

2 years ago

Prof. Dr. Dominik Ruettinger to lead Research and Early Development for Oncology at Bayer’s Pharmaceuticals Division

(PRESS RELEASE) BERLIN, 26-Jul-2021 — /EuropaWire/ — Bayer, a global enterprise with core competencies in the life science fields of…

3 years ago

Bayer AG proposes the total dividend payout to rise 11.1 percent

Total dividend payout rises 11.1 percent to EUR 2,067 million Leverkusen, 26-Feb-2016 — /EuropaWire/ —  At its meeting today (February…

8 years ago

Werner Baumann becomes the new Chairman of the Board of Management of Bayer AG

LEVERKUSEN, 26-Feb-2016 — /EuropaWire/ — Effective May 1, 2016, Werner Baumann will become the new Chairman of the Board of…

8 years ago

Bayer AG to sell its Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for EUR 1,022 million

Transaction includes blood glucose monitoring systems and lancing devices for people with diabetes LEVERKUSEN, 11-6-2015 — /EuropaWire/ — Bayer AG has…

9 years ago

Dr. Herbert Heitmann appointed Head of newly formed Communications and Government Relations unit at Bayer AG

Leverkusen, 23-5-2013 — /europawire.eu/ —  Dr. Herbert Heitmann, currently Executive Vice President of External Communications at Royal Dutch Shell, The…

11 years ago